Latest news with #patientmonitoring
Associated Press
20-06-2025
- Health
- Associated Press
NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
06/20/2025, Overland Park, Kansas // PRODIGY: Feature Story // After nearly a decade of development, testing, and clinical feedback, NthJEN LLC announces the launch of its breakthrough multi-sensor smart bed technology into the healthcare market. Designed to monitor immobility, alert clinicians of risk, and help prevent injuries, the solution stands at the intersection of compassion, precision, and innovation. Founder and CEO Naveen Gogumalla calls it 'a just-in-time, technology-based solution for one of the most overlooked problems in healthcare.' NthJEN's smart bed system, powered by a thin, pressure-sensitive membrane layered over any standard bed, uses over a thousand sensors to continuously map the patient's pressure distribution and activity. Unlike traditional methods that rely on visual checks or outdated alarms, the system detects early signs of immobility or unsafe patterns that can lead to pressure ulcers or dangerous falls. It can even detect if a patient has gotten out of bed and failed to return within a safe timeframe, alerting staff in real-time. 'It's not just about alarms, it's about precision alerts that matter,' says Gogumalla. 'We have designed this system to reduce alarm fatigue by only alerting caregivers when necessary. If the patient is out of bed too long or has not moved in a high-risk position, that's when the system speaks up.' The journey to market began in 2017, when Gogumalla, whose background spans IT and healthcare, was approached by a wound care nurse desperate for a real solution. 'She said everyone was trying to help us with these wounds, but no one was solving the core issue,' he recalls. Motivated by that challenge, and deeply affected by the untimely passing of his sister due to a cardiac event, Gogumalla redirected his efforts to build something that could truly make a difference. 'I kept thinking, how can we use technology to keep people safe? That's what drove this,' he says. What emerged was a durable medical device that could be prescribed by physicians, used in homes or care facilities, and integrated into existing hospital infrastructure. The product is durable, waterproof, and reusable. It straps securely to the bed, reads pressure changes through advanced sensors, and communicates data to clinicians and caregivers via a web-based dashboard. In the future, NthJEN aims to consolidate even more clinical monitoring into the device, vitals, telemetry, and ambient sensors, all in one discreet system. 'One of the core advantages is remote access,' says Gogumalla. 'Family members can receive email alerts or log in to view the bed status. In an age where loved ones are spread across cities or countries, this level of connection provides peace of mind.' Over five years of testing have proven the product's resilience in both clinical and home environments. The system's data logging capabilities can even aid litigation defense by documenting caregiver responses to alarms. According to Gogumalla, the solution helps not just the patient, but the entire ecosystem of care. 'This makes the caregiver more efficient. You don't need to walk in and check unless the alert tells you something's wrong. That changes everything,' he states. The market demand is clear. In the U.S. alone, pressure ulcers and falls account for over $50 billion in treatment and liability costs annually. With the smart bed's ability to detect inactivity or absence before harm occurs, NthJEN offers prevention, not just response. And while some competitors use in-room cameras or rudimentary pressure sensors, NthJEN stands apart. 'We are not trying to map wounds. We are trying to prevent them,' Gogumalla clarifies. 'And we don't believe in turning bedrooms into surveillance zones. This system respects patient dignity while still improving care.' Gogumalla and his team are already working with experienced physical therapists, home care networks, and hospitals to bring the solution into more hands. 'Our vision goes beyond the bed,' he adds. 'We are working toward a future where the hospital room is less cluttered, more integrated, and remotely accessible. Imagine a doctor standing on a beach and checking your vitals remotely from the same system.' For Gogumalla, though, the focus remains grounded. 'This is not about me,' he says. 'It's about solving a real problem and getting it into the hands of people who need it: nurses, patients, caregivers, families. That's who we built it for.' Media Contact Name: Naveen Gogumalla Email: [email protected] The information provided in this article is for educational and informational purposes only and is not intended as medical advice. It is not a substitute for professional medical diagnosis, treatment, or care. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. Source published by Submit Press Release >> NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
Khaleej Times
18-06-2025
- Health
- Khaleej Times
Inside UAE's most advanced cancer centre: Wearables, robotic surgery, carbon-ion therapy
From real-time patient monitoring and robotic surgery to genomic screening and heavy-ion therapy, Cleveland Clinic Abu Dhabi's Fatima bint Mubarak Center is progressing how cancer is diagnosed, treated, and prevented in the UAE. Marking its second anniversary, the centre's leadership presented a series of updates that reflect the growing scale and sophistication of the country's cancer care infrastructure. "We've treated over 27,000 cancer patients since inception," said Dr Stephen Grobmyer, Chief of the Cancer Institute. "But what's more exciting is where we're going." Wearables and cooling devices Among the most immediate changes affecting patients today is the roll-out of the BioButton, a medical-grade wearable that remotely tracks a patient's vital signs after chemotherapy or surgery. "We're putting it on almost all patients who start on chemotherapy," Dr Grobmyer confirmed, adding that it allows clinicians to identify signs of deterioration early and proactively intervene. "We can detect early warning signs like increased temperature or heart rate before the patient even notices. One of our patients, for example, was starting to experience complications like nausea and vomiting. We contacted them before it escalated, brought them in for fluids, and they were able to return home without hospital admission." The centre is also investing in supportive technologies to preserve the quality of life during treatment. Cooling caps, used to reduce chemotherapy-related hair loss, have already shown tangible results. "I had a patient last week who finished chemotherapy and still had almost all of her hair. She was very happy about that," said Dr Grobmyer. For patients facing neuropathy, a side effect of some cancer medications, cooling gloves are being used to reduce nerve damage in hands and feet. Robotic surgery = smaller cuts, faster recovery Dr Usman Ahmad, division chair of Thoracic Surgery, Heart, Vascular and Thoracic Institute, explained how Cleveland Clinic Abu Dhabi has made robotic and minimally invasive surgery the new norm for cancer patients across specialities. "There is no surgical treatment for which the patients have to leave the UAE now," he said. He emphasised the dramatic improvement in recovery times through robotic surgery. "Instead of big incisions, we operate through keyholes. Patients start walking the same day or the next, go home in a few days, and can start further treatment like chemotherapy or immunotherapy within a week or two." He described the shift from older surgical methods in vivid terms: "The robotic technology is so advanced that the instruments act like my hands inside the patient's body, without me having to put my hands inside. Traditional thoracic surgery might require an incision this big," he said, gesturing from his heart to the abdomen area. "Now, we do the entire operation through incisions the size of a fingertip." Dr Ahmad noted that nearly all types of cancer surgeries, including for lung, stomach, oesophagus, kidney, prostate, and ovarian cancers, are now performed robotically. "We don't compromise on safety or quality. These are the same standards you'd find in the US or Europe." AI, adaptive radiation and heavy ion therapy Radiation oncology has also seen a leap forward, with Cleveland Clinic Abu Dhabi now offering AI-powered adaptive radiation and brachytherapy, internal radiation delivered directly to the tumour. "Adaptive radiation is among the most advanced in the world," said Dr Fady Geara, Division Chair of Radiation Oncology. "We adjust the radiation in real-time during treatment to follow the tumour's exact position and spare healthy tissue." He added that this is especially useful for abdominal and pelvic cancers, where organs shift frequently. The centre's brachytherapy programme is now operating daily and, according to Dr Geara, is often "not even available in many US centres." As previously announced, the facility is preparing to launch the region's first carbon-ion therapy centre - a treatment for tumours resistant to traditional methods. "We're building a new facility to house the synchrotron accelerator," said Dr Geara. "We aim to treat our first patient in two to three years, or possibly sooner." Genomics, prevention, and regional leadership A polygenic risk score (PRS) study to predict breast cancer in patients without known genetic mutations is also underway. "Most global data is from Western populations," said Dr Fawad Khan, Staff Physician for Longevity Medicine. "We're now validating this in Emiratis, which will also benefit the wider Arab population." The hospital's longevity and high-risk prevention programmes already serve hundreds of patients, both survivors and those with elevated risk, including international patients from Saudi Arabia and Qatar. "This is not a branch of Cleveland Clinic," Dr. Grobmyer emphasised. "We are Cleveland Clinic. Our tumour boards include our colleagues in Ohio, and our goal is not just to take from the system but to contribute new knowledge back." Training the next generation As part of that long-term vision, the centre has received approval to launch a four-year oncology residency programme starting in 2026. "Our preference is to train locals - Emirati doctors, but we also bring in candidates from the wider region when needed," said Dr Grobmyer. He noted that the programme, accredited through the UAE's board system, is designed to match the standards of top US fellowships. "It's a long journey," he added, describing the structure as a progression from internal medicine training to subspecialty practice in solid tumour oncology and malignant haematology. Once trainees complete the full programme and pass board exams, "they will be independently able to manage the full spectrum of diseases," he explained, Dr Ahmad stressed how early detection saves lives, and no one in the UAE needs to leave the country for treatment as they could receive timely, high-quality, sufficient treatment in the capital. "While our technology is world-class, it's only useful if people get to us in time," he concluded.
Medical News Today
02-06-2025
- Business
- Medical News Today
IV infusions and Medicare: Coverage details
Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer the same services as Original Medicare, though a person's out-of-pocket costs will differ and will depend on their plan. This article discusses coverage options for IV infusions through Medicare. When does Medicare pay for IV infusions? Medicare Part A, Part B, and Medicare Advantage (Part C) plans generally all cover IV infusions if these are medically necessary. However, whether Medicare deems a person's IV infusion medically necessary depends on each case. That said, examples of medications or other liquids that healthcare professionals administer via an IV include : chemotherapy drugs Immunotherapy drugs targeted therapy drugs anti-nausea medicines hydration fluids antibiotics Any IV infusion must last at least 15 minutes to qualify under Medicare. In addition, Medicare will cover hydration therapy when medically necessary with an IV infusion, which is considered part of the same treatment as long as the hydration therapy lasts 20 to 30 minutes or less. Does Medicare cover IV infusion at home? Medicare Part B covers the equipment for home IV infusion under its durable medical equipment (DME) benefit. In addition, Part B will cover the infusion drugs themselves and support the infusion through nursing visits, caregiver training, and patient monitoring. Are infusions covered by Medicare Part D? Medicare Part D covers drugs that a person can administer themselves. Because individuals cannot administer their infusion, their IV infusion will fall under the coverage of Part B. How much does an IV infusion cost? Original Medicare comprises parts A and B. Part A covers hospitalization and general Medicare care. A person receiving an IV infusion during their hospital stay must meet a 2025 deductible of $1,676 before coverage begins. In most cases, people do not pay a premium for Part A. A person receiving infusion therapy under Part B must pay a premium that starts at $185, depending on their income, and meet a deductible of $257. After that, Part B pays for 80% of infusion costs. A person enrolled in a Part D plan will get the same coverage as under Part A and Part B. However, private insurers manage these plans, which have different premiums, deductibles, and coinsurances. According to the Centers for Medicare & Medicaid Services (CMS), the average monthly premium for Part C plans is around $17 in 2025. How much does home infusion therapy cost? How much IV infusion, whether at home or in a medical setting, might cost out of pocket before and after insurance depends on the type someone needs and the duration of the treatment. One 2023 review estimated the cost per day for home infusion to be $122 and for inpatient infusion to be $798. This review also examined six studies, finding that home infusion therapy could save significantly more money than inpatient infusion. One study reported savings of over $40,000 per patient, while another projected nearly $3 billion in savings for Medicare over 5 years. Medicare parts A, B, and C (Medicare Advantage) cover IV infusions if doctors deem them medically necessary. Part B also includes home IV infusion equipment under the durable medical equipment benefit, including infusion medications, nursing visits, caregiver training, and patient monitoring. A person enrolled in Part C will get equivalent coverage to parts A and B. A person needs to verify their hospital status — whether the hospital classifies them as an inpatient or outpatient — with their healthcare team. This can influence their out-of-pocket expenses and determine which part of Medicare will cover the services. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Yahoo
25-05-2025
- Health
- Yahoo
Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025
SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this advanced system provides industry-first innovations in ultrasound-integrated hemodynamic assessment and cable-lite patient monitoring workflow, redefining the bedside monitor as a dynamic hub of precision medicine. Ralph Zhao, General Manager of Sales & Marketing, Mindray Patient Monitoring & Life Support, shared: "Our new patient monitoring system future-proofs standards of care to help clinicians see patient status as a whole, making better use of multi-modal data from different devices for actionable insights." The increasing utilisation of point-of-care ultrasound in the ICU has transformed patient assessment and management. The new BeneVision V Series connects with ultrasound systems, including the TE Air handheld ultrasound, to systemically integrate imaging data for more insightful decision-making support. This bedside innovation enables clinicians to get clearer ultrasound images on screen, so they can visualise, analyse and document ultrasound findings both in real-time and through historical trends. The upgraded HemoSight™ tool aligns ultrasound-derived parameters with vital signs for synchronised evaluation, generating a more comprehensive hemodynamic profile for timely decision-making. The MRV PodTM is another innovative breakthrough that enhances vital signs monitoring in critical care, improving patient mobility and optimising clinical workflows. This industry-first, full-parameter, cable-lite solution transmits vital signs data wirelessly to the BeneVision V Series monitor. This frees patients from bedside cables, allowing unimpeded mobility while streamlining workflow and cable management for nurses. Combined with the widely recognised BeneVision N1 transport monitor, the new solution supports continuous monitoring during patient transport for efficient, integrated care. In addition, the top-of-the-line VMAX features a 4K UHD capacitive screen in an ultra-slim design. Its 360-degree visible alarm lights ensure critical alerts can be seen from any angle, minimising missed alarms and enhancing safety. The responsive touchscreen interface allows for smooth navigation and easy customisation. Clinicians can personalize displays with a simple drag-and-drop, and adjust waveform amplitude using pinch-to-zoom gestures. "Through our continued collaborations with hospitals and academic institutions, we strive to empower clinicians to provide more personalised and focused care, enhancing patient attention. We anticipate further collaborative outcomes that will lead to improved data analysis and applications for more efficient workflows," added Zhao. For more about Mindray, please visit View original content to download multimedia: SOURCE Mindray Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
